Binary Mixtures of Some Active Pharmaceutical Ingredients with Fatty Alcohols—The Criteria of Successful Eutectic Formation and Dissolution Improvement

Pharmaceutical eutectics are solid mixtures, where the crystals of active pharmaceutical ingredients (APIs) are finely divided in the phase-separated microstructures. The size reduction makes the eutectic formation a viable option to improve the dissolution rate of the poorly soluble APIs. In the pr...

Full description

Bibliographic Details
Published in:	Pharmaceutics
Main Authors:	Songhee Jin, Jisun Jang, Soyeon Lee, Il Won Kim
Format:	Article
Language:	English
Published:	MDPI AG 2020-11-01
Subjects:	active pharmaceutical ingredient fatty alcohol eutectic dissolution
Online Access:	https://www.mdpi.com/1999-4923/12/11/1098

Similar Items

Enhanced Dissolution of Naproxen by Combining Cocrystallization and Eutectic Formation
by: Hakyeong Kim, et al.
Published: (2021-04-01)

Eutectic Formation of Naproxen with Some Dicarboxylic Acids
by: Dahye Kim, et al.
Published: (2021-12-01)

Deep Eutectic Solvents and Pharmaceuticals
by: Sónia N. Pedro, et al.
Published: (2021-09-01)

Improving the Physicochemical and Biopharmaceutical Properties of Active Pharmaceutical Ingredients Derived from Traditional Chinese Medicine through Cocrystal Engineering
by: Danyingzi Guan, et al.
Published: (2021-12-01)

Enhance dissolution rate and solubility of solid drugs through pharmaceutical deep eutectic solvents
by: Idrees B. Qader
Published: (2021-06-01)

The Properties of Choline Chloride-based Deep Eutectic Solvents and their Performance in the Dissolution of Cellulose
by: Hongwei Ren, et al.
Published: (2016-05-01)

Investigation of the Storage and Stability as Well as the Dissolution Rate of Novel Ilaprazole/Xylitol Cocrystal
by: Sihyun Nam, et al.
Published: (2024-01-01)

THE MANUFACTURING OF PHARMACEUTICAL INGREDIENTS IN RUSSIAN FEDERATION: THE CRISIS AT THE TURN OF XX TO XXI CENTURIES
by: E. V. Denisova
Published: (2019-01-01)

Analysis of spironolactone polymorphs in active pharmaceutical ingredients and their effect on tablet dissolution profiles
by: Renata Cunha de Resende, et al.

Continuous-Flow Chemistry and Photochemistry for Manufacturing of Active Pharmaceutical Ingredients
by: Pavlína Horáková, et al.
Published: (2022-12-01)

Therapeutic Deep Eutectic Systems towards the Treatment of Tuberculosis and Colorectal Cancer: Opportunities and Challenges
by: Filipe Oliveira, et al.
Published: (2021-11-01)

Active pharmaceutical ingredients in dermatological medicines of Ukrainian pharmaceutical market
by: I. O. Vlasenko, et al.
Published: (2019-03-01)

Natural deep eutectic solvents for turbidity removal from synthetic pharmaceutical wastewater
by: Hayyan Adeeb, et al.
Published: (2024-01-01)

Ionic Liquids as Tools to Incorporate Pharmaceutical Ingredients into Biopolymer-Based Drug Delivery Systems
by: Paula Berton, et al.
Published: (2023-02-01)

Editorial: Medicinal chemistry of active pharmaceutical ingredients of drug products
by: Mohd Imran, et al.
Published: (2024-04-01)

USE OF DISSOLUTION TEST FOR EVALUATION OF PHARMACEUTICAL EQUIVALENCE OF ATORVASTATIN GENERICS
by: O. V. Druzhininskaya, et al.
Published: (2019-01-01)

Synthesis, Characterization, and Intrinsic Dissolution Studies of Drug–Drug Eutectic Solid Forms of Metformin Hydrochloride and Thiazide Diuretics
by: Guadalupe Coyote-Dotor, et al.
Published: (2021-11-01)

An improved procedure for synthesis of lenalidomide as an active pharmaceutical ingredient
by: Elaheh Ataollahi, et al.
Published: (2025-09-01)

Enhance dissolution rate and solubility of solid drugs through pharmaceutical deep eutectic solvents
by: Idrees Bakr Qader
Published: (2021-06-01)

Brazilian national production of active pharmaceutical ingredients: regulatory and strategic framework
by: MARLON DANIEL L. TONINI, et al.
Published: (2023-12-01)

Solubility and Stability of Some Pharmaceuticals in Natural Deep Eutectic Solvents-Based Formulations
by: Natali Rianika Mustafa, et al.
Published: (2021-04-01)

Modelling of the Erosive Dissolution of Metal Oxides in a Deep Eutectic Solvent—Choline Chloride/Sulfosalicylic Acid—Assisted by Ultrasonic Cavitation
by: Oleg M. Gradov, et al.
Published: (2021-12-01)

Occurrence and toxicological assessment of selected active pharmaceutical ingredients in effluents of pharmaceutical manufacturing plants and wastewater treatment plants in Kampala, Uganda
by: R. Kayiwa, et al.
Published: (2022-04-01)

Simple, Accurate and Multianalyte Determination of Thirteen Active Pharmaceutical Ingredients in Polypills by HPLC-DAD
by: Barbara Żuromska-Witek, et al.
Published: (2022-12-01)

Pharmaceutical compounding of orphan active ingredients in Belgium: how community and hospital pharmacists can address the needs of patients with rare diseases
by: V. Vanhoorne, et al.
Published: (2019-08-01)

Novel Solvent Systems for Cellulose Dissolution
by: Jianbo Shuai, et al.
Published: (2021-02-01)

Modification of the Physicochemical Properties of Active Pharmaceutical Ingredients via Lyophilization
by: Amir Taldaev, et al.
Published: (2023-11-01)

Review of Medicinal Plants and Active Pharmaceutical Ingredients against Aquatic Pathogenic Viruses
by: Wenyu Liao, et al.
Published: (2022-06-01)

Pervaporation-assisted crystallization of active pharmaceutical ingredients (APIs)
by: Claire Schmitz, et al.
Published: (2023-01-01)

Electrochemical etching of metals and minerals using ultrasound in deep eutectic solvents
by: Philip Hunt, et al.
Published: (2025-08-01)

Stability and Dissolution Behavior Changes After Drug Compounding for Pediatric Cardiovascular Pharmacotherapy
by: Jumpei Saito, et al.
Published: (2025-04-01)

Solubility, Permeability, and Dissolution Rate of Naftidrofuryl Oxalate Based on BCS Criteria
by: Marta Kus-Slowinska, et al.
Published: (2020-12-01)

Natural Deep Eutectic Solvents (NADES): Phytochemical Extraction Performance Enhancer for Pharmaceutical and Nutraceutical Product Development
by: Ni Putu Ermi Hikmawanti, et al.
Published: (2021-10-01)

Promoting local production and active pharmaceutical ingredient (API) industry in low and middle income countries (LMICs): impact on medicines access and policy
by: Muhammad Akhtar Abbas Khan, et al.
Published: (2024-12-01)

Flavonoid-containing copolymers can act as both extended-release excipients and active pharmaceutical ingredients for the treatment of diabetes
by: Shicui Luo, et al.
Published: (2025-10-01)

DEVELOPMENT AND VALIDATION OF METHOD OF QUANTITATIVE DETERMINATION OF RESIDUAL ORGANIC SOLVENTS IN INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENT WITH GC-FID
by: E. V. Butina, et al.
Published: (2019-01-01)

Saquinavir-Piperine Eutectic Mixture: Preparation, Characterization, and Dissolution Profile
by: Cinira Fandaruff, et al.
Published: (2023-10-01)

Ginsenoside Re as a Probe for Evaluating the Catalytic Potential of Microcrystalline Cellulose for the Degradation of Active Pharmaceutical Ingredients
by: Xinyu Gao, et al.
Published: (2025-06-01)

Investigating the novel process for thorough removal of eutectic phosphate impurities from phosphogypsum
by: Xinfeng Lv, et al.
Published: (2023-05-01)

Transferring Crystallization Conditions from Small to Larger Scale for Achieving Targeted Crystal Morphologies of an Active Pharmaceutical Ingredient
by: Nicolás Antonio Ramos Ojeda, et al.
Published: (2023-12-01)